Considering the CD8+/CD4+ ratio, it has been shown that a high baseline CD8+/CD4+ ratio in peripheral blood correlates statistically significantly with a better prognosis in early-stage NSCLC (HR 0.19) [50]. Here, CD4 is linked to non-small cell lung carcinoma.